Title : HDAC6-mediated EGFR stabilization and activation restrict cell response to sorafenib in non-small cell lung cancer cells.

Pub. Date : 2016 May

PMID : 27090797






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 HDAC6-mediated EGFR stabilization and activation restrict cell response to sorafenib in non-small cell lung cancer cells. Sorafenib histone deacetylase 6 Homo sapiens
2 Overexpression of HDAC6 confers resistance to sorafenib in NSCLC cells. Sorafenib histone deacetylase 6 Homo sapiens
3 Inhibition of HDAC6 with selective inhibitors synergizes with sorafenib to kill NSCLC cells via inhibition of sorafenib-mediated EGFR pathway activation. Sorafenib histone deacetylase 6 Homo sapiens
4 Inhibition of HDAC6 with selective inhibitors synergizes with sorafenib to kill NSCLC cells via inhibition of sorafenib-mediated EGFR pathway activation. Sorafenib histone deacetylase 6 Homo sapiens